eberconazole has been researched along with Dermatomycoses in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carol, F; Gnaneshwar, R; Jerajani, HR; Krishnankutty, B; Kumar, AS; Kuruvila, M; Latha, MS; Martis, J | 1 |
| Badell, A; del Rio, R; Gratacós, MR; López, S; Repiso Montero, T; Rodríguez, C | 1 |
| del Palacio, A; Font, E; Garau, M; Ortiz, FJ; Pazos, C; Pérez, A | 1 |
3 trial(s) available for eberconazole and Dermatomycoses
| Article | Year |
|---|---|
The Efficacy and Safety of Eberconazole Nitrate 1% and Mometasone Furoate 0.1% w/w Cream in Subjects with Inflamed Cutaneous Mycoses.
Topics: Adolescent; Adult; Aged; Cycloheptanes; Dermatologic Agents; Dermatomycoses; Dosage Forms; Female; Humans; Imidazoles; Male; Middle Aged; Mometasone Furoate; Prospective Studies; Treatment Outcome; Young Adult | 2015 |
Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream.
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Cycloheptanes; Dermatomycoses; Double-Blind Method; Female; Humans; Imidazoles; Male; Miconazole; Middle Aged; Severity of Illness Index; Spain; Treatment Outcome | 2006 |
A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections.
Topics: Administration, Topical; Antifungal Agents; Arthrodermataceae; Candida; Candidiasis; Clotrimazole; Cycloheptanes; Dermatomycoses; Double-Blind Method; Epidermophyton; Humans; Imidazoles; Treatment Outcome; Trichophyton | 2001 |
1 other study(ies) available for eberconazole and Dermatomycoses
| Article | Year |
|---|---|
Eberconazole (Eberconazol, Eberconazole nitrate, WAS 2160).
Topics: Antifungal Agents; Clinical Trials, Phase II as Topic; Cycloheptanes; Dermatomycoses; Humans; Imidazoles | 2002 |